Advanced therapy classification
Companies can consult the European Medicines Agency (EMA) to determine whether a medicine they are developing is an advanced therapy medicinal product (ATMP). The procedure allows them to receive confirmation that a medicine - which is based on genes, cells or tissues - meets the scientific criteria for defining an ATMP.
Human
Advanced therapies
Regulatory and procedural guidance